Sign in

CIK 0001321732

  • Large accelerated filer

Penumbra Inc

Sign in to watch
Ticker
PEN
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-995-2486
Business address
ONE PENUMBRA PLACE, ALAMEDA, CA, 94502
  1. 4 Planned sale Director sold 186 shares at $248.61 ($46,241)
  2. 4 Planned sale EVP, Gen. Counsel & Secretary sold 600 shares at an average $249.70 ($149,820)
  3. 4 Planned sale Director sold 186 shares at $253.93 ($47,231)
  4. 4 Grant or award President acquired 9,170 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Planned sale Director sold 186 shares at $272.19 ($50,627)
  7. 4 Planned sale CEO sold 15,800 shares at an average $269.65 ($4,260,457)
  8. 4 Planned sale EVP, Gen. Counsel & Secretary sold 600 shares at an average $270.58 ($162,347)
  9. 4 Planned sale CEO and President sold 15,900 shares at an average $254.53 ($4,046,952)
  10. 4 Planned sale Chief Financial Officer sold 2,000 shares at $250.00 ($500,000)
  11. 4 Planned sale Director sold 12,000 shares at an average $250.65 ($3,007,776)
  12. 4 Planned sale Director sold 372 shares at $240.16 ($89,340)
  13. 4 Planned sale EVP, Gen. Counsel & Secretary sold 600 shares at an average $238.94 ($143,363)
  14. 4 Planned sale CEO and President sold 16,030 shares at an average $238.20 ($3,818,363)
  15. 4 Planned sale CEO and President sold 16,150 shares at an average $233.16 ($3,765,574)
  16. 4 Planned sale CEO and President sold 15,985 shares at an average $243.75 ($3,896,344)
  17. 4 Planned sale EVP, Gen. Counsel & Secretary sold 600 shares at an average $252.70 ($151,622)
  18. 4 Option exercise EVP, Gen. Counsel & Secretary acquired 1,943 shares (option exercise)
  19. 4 Planned sale CEO and President sold 15,890 shares at an average $253.40 ($4,026,589)
  20. 4 Planned sale Director sold 50 shares at $259.78 ($12,989)

Page 3 of 30 · 592 filings